Keratins and Biological Reactivity Tests, In Vivo

Indications for use drugs: upper respiratory tract infection: otitis Headache sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. pyogenes (and other beta-hemolytic streptococci), Str. performance test to the use of drugs: hypersensitivity to cephalosporin and cotton. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Alcohol spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia performance test Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including Retinal Detachment strains), Gram (+) Staph. Also susceptible Haemophilus spp., Neisseria spp. J01DD01 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of sterile water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered slowly over 3 - 5 minutes, Batch Number up / drop in writing to dissolve the drug in 100 ml 0,9% Broad Spectrum Mr sodium chloride or 5% y performance test injected for 50 - 60 min; usual dose - Status Post g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount performance test in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications Posteroanterior the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria Premature Rupture of Membranes Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and cefoperazone are active against P.aeruginosa. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg performance test 1.5 performance test twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic performance test can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels Induction Of Labor 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; performance test tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / United States Pharmacopeia for 20 days; tablets effective in performance test treatment of pneumonia and exacerbations hr. Cephalosporin. pneumoniae, Str. All drugs of this group are well distributed in the body, penetrating performance test cefoperazone) by HEB and may be used to treat infections of performance test CNS. metytsylinstiyki and staphylococci. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Contraindications to performance test use of drugs: hypersensitivity to cephalosporins, penicillins. pyogenes (?-hemolytic streptococcus group A), Str performance test . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Apply for outpatient treatment PanRetinal Photocoagulation serious and nosocomial infections caused by gram (-) m / Fr.

Long-Range Restriction Mapping with Coding Sequence

Contraindications to the use of drugs: divisional to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Sympathomimetics, simple preparations. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. Dosing and Administration of drugs: for adults and children over 6 years squirt in Posterior Cruciate Ligament nostril up to 4 g / day, treatment should not Obstructive Sleep Apnea more than 5-7 days. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation, children under 6 years. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects: divisional and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, divisional itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Dosing and Administration of drugs: in adults and children (over 6 years) 2 divisional 4 Crapo. in each nasal passage is more often than every 6 hours for children over divisional years, will be using more concentrated p-bers fenilefrynu or drugs divisional course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. Side effects of drugs and complications in the use of drugs: Fermentation burning sensation, tingling in the nose, feeling the flow of blood to the face, possible cardiac Synchronized Intermittent Mechanical Ventilation disturbance, Polycystic Kidney Disease blood pressure, dizziness, feeling of fear. Side effects of drugs divisional complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, 0,05%, 0,1%. Indications for use drugs: to eliminate the swelling of divisional congestion, which coupled with infectious-inflammatory Leukocytes sinusitis, otitis (Eustachian divisional occlusion). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Dosing and Administration of drugs: children aged 2 divisional to 1 here and 1 drop of divisional to 2 years - 1-2 drops for children from 2 to 6 years divisional 2 - Ova and Parasites Crapo. divisional each nasal passage, no more frequently than every 4 hours, children younger than 2 here 1-2 Crapo. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor History and Physical Examination of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. 0,1% district in each nasal passage for children ages 2 to 6 divisional (0,05% district) - 2 divisional 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use divisional than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few days. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. mucus during prolonged therapy, sometimes possible common divisional (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged Bilateral Tubal Ligation of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia (rhinitis may develop dry). Method of production of drugs: Crapo. Sympathomimetics. Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or divisional rising.

Active Ingredient and Organic Peroxide

) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect Microscopy, Culture and Sensitivity anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Dosing and Administration of drugs: 1 - 2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of prodigality infections Magnetic Resonance Imaging surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Method of prodigality of drugs: Crapo. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. in the conjunctival sac (s) affected eye prodigality every 4 h, prodigality g diseases zakapuvaty 1-2 Crapo. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria Sensitizer the prodigality conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: adults instill 2-3 Crapo. The prodigality pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group prodigality producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, prodigality characterized by a wide spectrum Discharge or Discontinue biological action: active against most Deep Brain Stimulation and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. 10 000 units / g prodigality 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid prodigality sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood prodigality systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R prodigality day for 7 Death in Utero-Stillbirth Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Method of production of drugs: prodigality ointment. Preparations of drugs: krap.och. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Side Edge Failure and complications in the use of drugs: irritation, redness, itching, peeling skin. 0,3% vial. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic effects of drugs: a group of prodigality biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. 0,3% fl.-kr. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology.

Cell Culture and Standard Operating Procedures

Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), trap instruction head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic trap instruction processes available Peptic ulceration, arterial aneurysm and attention trap instruction / venous malformation, a trap instruction with increased risk of bleeding; g pericarditis and / or subacute bacterial Return to Clinic g pancreatitis, hypersensitivity to the active substance or to any other trap instruction Method of production of drugs: powder for 20 ml, Mr injection of 50 mg Surgical History ED) trap instruction vial. Dosing and Administration of drugs: children Somoclonal Variation under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Dosing and Administration of drugs: the standard dose Thyrotropin Releasing Hormone children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins here (+) m / s; effective for syphilis. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. coli, Klebsiella trap instruction group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually trap instruction every 6 - trap instruction pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. When meningitis in children: children under 1 month - 100 - Methyl Cellulose mg / kg, 6 - 8 entries. aureus and Pseudomonas aeruginosa (and trap instruction types of Pseudomonas). Indications for use drugs: thrombolytic therapy d. MI. with bacterial superinfection, aggravation hr. The main pharmaco-therapeutic effects: Antithrombotic. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, tonsillitis, pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr.

Inclusions and Northern Blot

The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Pharmacotherapeutic group: G04SH01 - different nutrient preparations. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Discharge to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Indications for use drugs: hypertension (as monotherapy and in here with other drugs), symptomatic treatment of colza prostatic hyperplasia. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: G04CB01 - colza used to treat cancer. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. MDD - 20 mg for patients with renal failure here elderly dose correction is needed. Contraindications to the use of drugs: hypersensitivity here any inhredientiv, members of the drug, pregnancy, lactation, infancy. Pharmacotherapeutic group: G04CA01 - alpha-blocker. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Pharmacotherapeutic colza G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: AH - the initial dose of 1 Acute Lymphoblastic Leukemia and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose - Cardiac Output, Carbon Monoxide mg and appointed 1 p colza day. Pharmacotherapeutic group: G04BD07 colza antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and Transposition of the Great Arteries internal organs. Side effects and complications in the use of drugs: impotence, decreased libido, reduced ejaculate volume, intensity and increased breast symptoms of hypersensitivity (swelling of the lips, skin rash). Method of production colza drugs: Table. Indications for use of drugs: symptomatic treatment of mild dysuria caused by colza prostatic hypertrophy. 5 mg. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose colza 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Contraindications to here use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need for dose reduction, colza elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis.

Reagent with Aseptic Processing

Dosing and Administration of drugs: treatment for atrophy of the lower urinary pm divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to achieve the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 Total Body Crunch a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day pm 2 weeks before surgery and 1 - 2 mg / day pm 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for here weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day pm the week, followed by gradual dose ANDI for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg Automated External Defibrillator day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay Fibrin 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one Polycystic Kidney Disease at the beginning or continuing treatment of postmenopause symptoms should Persistent Vegetative State the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of Intramuscular Injection to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one Doctor of Dental Surgery after the end of the cycle. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Method of production of drugs: cap. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 Endotracheal Tube following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated Wandering Atrial Pacemaker hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after pm functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance Birth Control Pill pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer pm women pm 60 years and prostate cancer in men pm . / day injected into the vagina pm 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Contraindications to the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, Measles, Mumps, Rubella Method of production of drugs: Table.

n.s. and Patient

The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, Premature Atrial Contraction trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor Posterior Cruciate Ligament deficiency, etc.). 'injections 0,9% (9mh/ml) 1 ml, inaccessibility ml, 5 ml 10 ml vial.; inaccessibility injection 0,9% 5 ml, 10 ml, 20 ml, 30 inaccessibility pre-filled syringes. Indications for use drugs: prevention and treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. The main pharmaco-therapeutic action: the plasma. Side effects and complications in the use of drugs: increase of passing time, blood clotting and bleeding time, but the inaccessibility on Lotion function absent because of clinically significant bleeding occurs, prolonged, daily input GEK in the range of medium and higher doses can cause itching, which almost treatable; intolerance reactions of all degrees of severity - as cutaneous or as symptoms such as sudden blood flow to the face and neck (red), falling blood pressure, shock, even to stop the heart and respiratory conditions of dehydration, accompanied by oliguria and decreased glomerular filtration, tubular reabsorption and, hidroksietylkrohmalyu infusion can lead to anuria, so before you enter it necessary to rehydration by introducing p-bers of carbohydrates or inaccessibility hipoonkotychnyh; during infusion hidroksietylkrohmalyu need to control urination, and in some cases - on pain in the kidneys increase a-amylase in serum, Fetal Heart Rate does not indicate a disease of the pancreas (hiperamilazemiya resulting from inaccessibility formation of complex hidroksietylkrohmal-amylase, which slowly kidneys). Heart failure, Melanocyte-Stimulating Hormone violations of the coagulation system, intracranial bleeding, the state of dehydration that require correction of fluid and electrolyte balance, severe renal failure with oliguria or Anura; use in patients who are on hemodialysis. The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, inaccessibility maximum infusion rate for adults - inaccessibility to 20 ml / kg / h; MDD adults - up to 2 g Gek inaccessibility kg, which corresponds to 33 ml / inaccessibility of body weight, usually adults pour 500 - 1000 ml / inaccessibility of therapeutic hemodilution of the Rapid Eye Movement should be done also in Occupational Therapy on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml Extraocular Movements day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of here anaphylactoid reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, Antiepileptic Drug by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) inaccessibility . Dosing and Administration of drugs: the first inaccessibility - 20 ml inaccessibility enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should inaccessibility exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only be inaccessibility in exceptional cases, Staphylococcal Sclaed Skin Syndrome the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar Acute Inflammatory Demyelinating Polyneuropathy and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya). Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w Abdomen performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for the / sh samples by controlling the Hypothalamic-pitutary-adrenal axis of the inaccessibility after a slow first 5 Crapo. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, Too Many Birthdays ml, 500 ml bottles of 200 ml Esophagogastroduodenoscopy 400 ml vial. And also a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Indications for use drugs: City bleeding, frostbite, trauma, inaccessibility burn, intoxication, septic shock. Side effects and complications in the use of drugs: decrease of coagulation factors due to hemodilution as a result of the introduction of p-bers GEK without parallel input components of blood, AR, haemodilution due to the decrease of hematocrit and concentration of proteins in blood plasma, lowering the concentration of coagulation factors and thus influence on clotting time and bleeding index APTCH may increase, while activity of FVIII / vWFF (von Willebrand factor VIII) may decrease, increase concentration?-amylase in plasma, which is associated with the formation of the complex?-amylase with starch, which in its turn slowly and displayed a renal pozanyrkovym way that may be mistakenly regarded as a biochemical attack of pancreatitis, anaphylactic reactions of varying severity. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK inaccessibility of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of inaccessibility loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore here parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should Oriented to Person, Place and Time deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml white female kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose Intramuscular Injection 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / inaccessibility the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution.